Sebacia, Inc.   Report issue

For profit
Founded: Duluth GA United States (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2018
NCT03573115
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Sebacia, Inc.